Sodium Chloride

Introduction Overview

Generic Name

Sodium Chloride

Brand Name

Dey-Pak

Dosage Form

Oral inhalation solution for nebulization, parenteral injection (various concentrations)

Drug Class

Replacement Preparations

Pharmacokinetics

Absorption: Sodium chloride, when administered orally or parenterally, dissociates into sodium and chloride ions that are readily absorbed and distributed throughout the extracellular fluid compartment. Oral absorption is rapid and complete, while intravenous administration delivers sodium and chloride directly into the systemic circulation, ensuring immediate electrolyte replenishment. The rate of absorption may be influenced by the route of administration and the concentration of the administered solution.

Distribution: Sodium chloride is primarily distributed in the extracellular fluid, which includes interstitial fluid and plasma, reflecting its role in maintaining osmotic balance and fluid volume. The distribution volume corresponds closely to extracellular fluid volume, approximately 0.2 L/kg. It is not known whether sodium chloride is significantly distributed into milk or crosses other biological barriers extensively due to its ionic nature. Additionally, sodium ions are principal extracellular cations controlling water distribution and osmotic pressure, while chloride ions represent the major extracellular anions contributing to acid-base equilibrium.

Metabolism: Sodium chloride is an inorganic compound and does not undergo metabolism. Instead, its physiological effects are exerted directly through ionic interactions affecting fluid balance, nerve conduction, and enzymatic activities critical for cellular function.

Elimination: The primary route of elimination of sodium and chloride ions is renal excretion. The kidneys regulate sodium and chloride homeostasis through filtration, reabsorption, and secretion processes, adapting excretion according to body requirements. In patients with renal insufficiency, sodium retention can occur, necessitating careful monitoring and dose adjustment to avoid fluid overload and electrolyte imbalances. Sodium chloride does not undergo biotransformation, and excess amounts are eliminated unchanged in urine. The elimination rate is influenced by renal function, fluid status, and concomitant medications affecting renal perfusion or tubular function.

Dosage Forms

Available Dosage Forms:
- Oral inhalation solution for nebulization: 0.9%, 3%, and 10% concentrations (e.g., Dey-Pak Sodium Chloride Solution).
- Parenteral injections (intravenous): 0.45%, 0.9% (normal saline), 3%, and 5% sodium chloride injection solutions.
- Highly concentrated additive solutions for IV admixtures: 14.6% and 23.4% sodium chloride injection concentrates (pharmacy bulk packages).
- Bacteriostatic sodium chloride injections containing preservatives like benzyl alcohol (0.9%) for specific uses.

Dosages for Adults and Adolescents:
- Oral: 1–2 g orally three times daily to meet sodium and chloride requirements.
- IV: Maintenance or replacement using isotonic 0.9% sodium chloride injection at approximately 1 L daily or hypotonic 0.45% sodium chloride injections 1–2 L daily based on clinical status.
- Hypertonic solutions (3% or 5%) administered slowly, e.g., initial 100 mL infused over 1 hour for rapid electrolyte repletion; maximum 100 mL/hour infusion rate and not exceeding 400 mL in 24 hours.
- Additive solutions (14.6% and 23.4%) diluted prior to administration with compatible IV fluids; dosage individualized based on patient needs.
- Inhalation: prescribed concentrations nebulized for respiratory indications, including cystic fibrosis treatment (7% off-label use).

Specific Patient Populations:
- Pediatric: Dose individualized based on weight and clinical condition; bacteriostatic sodium chloride injection contraindicated in neonates due to risk of benzyl alcohol toxicity.
- Renal and hepatic impairment: Dosage adjustments required with caution due to altered sodium handling and risk of fluid overload.
- Geriatric: Start at lower end of dosing range due to reduced organ function and risk of sodium retention.

Extemporaneously compounded oral liquids standardized at 4 mEq/mL as per Standardize 4 Safety (S4S) initiative to reduce medication errors, with caution exercised when concentrations differ from labeling recommendations.

Mechanism Of Action

Sodium chloride serves as a critical source of sodium and chloride ions, which are indispensable electrolytes involved in maintaining extracellular fluid volume, osmotic pressure, and acid-base homeostasis. Upon administration, sodium ions act chiefly as the main cation in extracellular fluid, regulating water distribution between compartments through osmotic gradients, thereby influencing blood volume and pressure.

Chloride ions, as the principal extracellular anions, participate substantially in acid-base balance by buffering hydrogen ions, primarily through red blood cell buffering mechanisms involving oxygen and carbon dioxide exchange. This maintains physiological pH levels and supports cellular respiration.

The administration of sodium chloride solutions replenishes extracellular deficits of these ions during states such as dehydration, electrolyte imbalances, or fluid loss through sweat, vomiting, or diarrhea. Hypertonic sodium chloride solutions induce osmotic shifts drawing fluid into the intravascular compartment, thereby restoring circulating volume in severe depletion scenarios.

At the cellular level, sodium is essential for generating membrane potential and action potentials in excitable tissues such as nerves and muscles. Chloride contributes to maintaining electrochemical gradients vital for nerve conduction and muscle contraction. Clinically, replenishment with sodium chloride supports normal cellular function and prevents or corrects hyponatremia and hypochloremia, which can lead to neurological and metabolic disturbances.

Comparatively, sodium chloride is a fundamental electrolyte replacement without direct pharmacologic receptor activity but works synergistically alongside other electrolyte agents and fluid therapies to restore homeostasis. Clinical studies validate its efficacy in managing extracellular fluid deficits, hyponatremia, and as a diluent for compatible parenteral drugs.

Pharmacological Actions

Replenishment of sodium and chloride ions essential for cellular and extracellular fluid homeostasis.
Maintenance and restoration of intravascular volume through osmotic effects of various solution tonicity.
Supports acid-base balance by providing chloride ions which participate in buffering systems.
Facilitates nerve conduction and muscle contraction by maintaining membrane potentials.
Induces diuresis depending on volume and clinical context.
Serves as a diluent and vehicle for parenteral drug administration, ensuring compatibility and stability.
Assists in prevention of muscle cramps and heat prostration secondary to sodium and water loss.
Used as a priming fluid during hemodialysis and for thermodilution cardiac output measurement.
Nebulized solutions facilitate respiratory tract hydration and mucus clearance, particularly in cystic fibrosis.
Corrects or prevents electrolyte imbalances caused by excessive diuresis, salt restriction, or fluid therapy.

Therapeutic Or Clinical Uses

Maintenance and replacement therapy for sodium chloride and water in dehydration states.
Treatment of hyponatremia and hypochloremia resulting from sodium-free fluid administration or dilutional states.
Management of metabolic alkalosis in the setting of fluid losses and mild sodium depletion.
Extracellular fluid volume expansion in hypovolemia, shock, or during surgery and postoperative care.
Correction of severe sodium chloride depletion in conditions such as heart failure, renal impairment, and excessive fluid loss.
Hyperosmolar diabetes management using hypotonic sodium chloride solutions.
Assessment of renal function via isotonic 0.45% sodium chloride injection.
Priming of hemodialysis equipment and prevention of red blood cell hemolysis during blood transfusions.
Nebulized sodium chloride solutions for respiratory therapy including tracheal lavage and mucus clearance in cystic fibrosis (off-label).
Diluent for compatible injectable drugs and as part of infusion therapy regimens.
Measurement of cardiac output using thermodilution methods with 0.9% sodium chloride injections.
Prevention of muscle cramps and heat prostration secondary to fluid and electrolyte losses during heat exposure.

Side Or Adverse Effects

Local infusion site reactions including pain, phlebitis, infection, thrombosis, and extravasation.
Fluid overload leading to edema, congestive heart failure exacerbation, and pulmonary edema, especially with hypertonic solutions.
Electrolyte imbalances such as hypernatremia due to excessive sodium administration.
Dilutional electrolyte disturbances, including hypokalemia from prolonged use of potassium-free solutions.
Acidifying effects secondary to chloride ion load causing bicarbonate ion loss.
Tissue and systemic toxicity from preservatives such as benzyl alcohol in neonates (benzyl alcohol toxicity).
Risk of vein damage and irritation with hypertonic NaCl solutions (≥3%).
Potential CNS symptoms such as disorientation, weakness, or confusion from rapid sodium shifts.
Allergic or hypersensitivity reactions are rare but possible.
Risks associated with improper dilution and administration such as sudden hypernatremia, cardiovascular shock, or renal cortical necrosis.
Aluminum toxicity with prolonged parenteral use in patients with impaired renal function or neonates.
Overhydration leading to hyponatremia or volume overload in susceptible individuals.

Precautions

Monitor fluid, electrolyte, and acid-base status frequently, especially during prolonged therapy or in critical illness.
Use with caution in patients with renal insufficiency, cardiac dysfunction, or conditions predisposing to sodium retention.
Doses must be tailored considering patient's age, weight, clinical condition, and lab parameters.
Avoid rapid administration of hypertonic sodium chloride to prevent vein irritation and systemic imbalances.
In neonates, avoid bacteriostatic sodium chloride preparations containing benzyl alcohol due to toxicity risk.
Exercise caution in hepatic impairment, cirrhosis, and in geriatric patients due to altered sodium and fluid handling.
Dilute highly concentrated sodium chloride solutions appropriately prior to IV administration.
Observe for signs of fluid overload such as edema, respiratory distress, or hypertension.
Avoid use in patients with hypernatremia or when sodium or chloride administration is contraindicated.
Ensure compatibility when used as a diluent or additive for parenteral drugs.
Use extreme caution or avoid in patients undergoing surgery unless salt depletion is documented.
Educate patients on reporting concomitant medications or illnesses that may influence therapy safety.
Monitor for benzyl alcohol toxicity signs when using preservative-containing formulations.
Be aware of potential aluminum exposure from parenteral solutions, especially in neonates and renal failure.

Warnings

Avoid use during and immediately after surgery unless salt depletion factors are present; renal retention of sodium may cause fluid retention and edema.
Risk of sodium retention and fluid overload in patients with cardiovascular, renal insufficiency, or hypervolemia.
Hypertonic sodium chloride injections (3% and 5%) can cause severe local vein irritation and damage if extravasated.
Dilutional and solute overload risks are related to concentration and rate of administration; monitor patient closely.
Bacteriostatic sodium chloride injection contraindicated in neonates due to benzyl alcohol toxicity risk.
High sodium loads may exacerbate hypertension and congestive heart failure.
Infusion site infections, thrombosis, and phlebitis can occur; proper aseptic technique is essential.
Premature neonates and patients with impaired renal function at risk for aluminum toxicity from contaminated solutions.
Risk of sudden and severe hypernatremia if hypertonic solutions are administered undiluted or too rapidly.
Some preparations contain preservatives which may cause hypersensitivity or toxicity in susceptible patients.
Avoid prolonged use without monitoring to prevent electrolyte imbalances and acid-base disturbances.
Not for injection via routes other than prescribed, e.g., thermodilution solutions must be delivered solely by thermodilution catheters.
Use caution in geriatrics due to age-related decreased organ function influencing sodium and fluid handling.

Contraindication

Known hypernatremia or hyperchloremia where additional sodium or chloride administration is harmful.
Neonates for bacteriostatic sodium chloride injection due to preservative benzyl alcohol toxicity risks.
Patients with fluid retention states without documented salt depletion (3% and 5% sodium chloride injections).
Administration of 0.9% sodium chloride injection via thermodilution systems is contraindicated by any route other than thermodilution catheter.
Severe hypernatremia or fluid overload conditions where sodium chloride infusion would exacerbate clinical status.
Hypersensitivity to sodium chloride or any components of the preparation.
Patients with uncorrected hypervolemia or circulatory overload risks where sodium administration poses a threat.
Use of hypertonic sodium chloride without proper dilution in peripheral veins.
Severe electrolyte imbalance where sodium chloride replacement is contraindicated per clinical assessment.
Administration of 14.6% sodium chloride injection in hypernatremic or fluid retention patients.

Drug Interactions

Corticosteroids may increase risk of sodium retention and exacerbate edema or hypertension; use with caution.
Corticotropin can potentiate sodium retention; monitor fluid status closely when used concomitantly.
Drugs causing renal impairment may alter sodium excretion leading to accumulation and toxicity.
Concomitant use with diuretics requires careful monitoring of serum electrolytes due to additive effects on sodium and chloride balance.
Combining with other hypertonic solutions may increase risk of fluid and solute overload.
Co-administration with antihypertensives might reduce their efficacy due to sodium-induced volume expansion.
Drugs dissolved or diluted in sodium chloride solutions require evaluation for compatibility and stability.
Agents affecting acid-base balance might interact with sodium chloride's influence on bicarbonate levels.
Lithium treatment may be affected by sodium intake alterations, influencing lithium clearance.
NSAIDs can impair renal function, increasing risk of sodium retention and fluid overload.
Medications causing electrolyte disturbances may have additive or opposing effects when used with sodium chloride.
Caution when used with intravenous drugs with narrow therapeutic index requiring stable fluid and electrolyte status.
Use of sodium chloride as a diluent may alter pharmacokinetics of co-administered injectable drugs.

Preparations Of The Drug

Dey-Pak Sodium Chloride Solution for nebulization: 0.9%, 3%, and 10% concentrations.
Dey-Vial Sodium Chloride Solution for inhalation: 0.9%, 3%, and 10%.
Sodium Chloride Inhalation Solution by Nephron: 0.9%.
Parenteral injections by Baxter: 0.45%, 0.9%, 3%, and 5% sodium chloride injections, including hypertonic solutions.
Thermoject system by Hospira: 0.9% sodium chloride injection with injector and temperature probe for cardiac output measurement.
Pharmacy bulk packages by Abraxis: Sodium chloride additive solutions at 2.5 mEq/mL and 4 mEq/mL strengths.
Bacteriostatic Sodium Chloride Injection (0.9% with benzyl alcohol or parabens) by American Regent.
Extemporaneously compounded oral liquid standardized at 4 mEq/mL per Standardize 4 Safety initiative.
IV concentrated additive solutions (14.6% and 23.4%) requiring dilution prior to administration.
Available sterile inhalation solutions in single-dose containers for nebulization and tracheal irrigation.
Preparations containing preservatives such as benzyl alcohol excluded for use in neonates due to toxicity risks.
Commercially available formulations meet specified storage conditions (generally room temperature, some 15–30°C).
Various manufacturers and distributors provide generic sodium chloride in multiple formulations and concentrations to meet clinical needs.